---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-054842"
form_type: "8-K"
ticker: "BRVE"
cik: "0002131524"
company_name: "Braveheart Bio, Inc."
filed_at: "2026-08-07T20:14:14+00:00"
generated_at: "2026-08-07T20:15:07.103978+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Braveheart Bio files amended charter and bylaws post-IPO, authorizing 500M common shares

## Summary
- Second amended and restated certificate of incorporation filed with Delaware on Aug 7, 2026, effective immediately prior to IPO completion.
- Authorizes 500,000,000 shares of common stock and 10,000,000 shares of undesignated preferred stock.
- Eliminates prior preferred stock series and removes stockholder ability to act by written consent or call special meetings.
- Amended and restated bylaws establish advance notice procedures for stockholder proposals and board nominations.

## SEC filing metadata
- accession: 0001628280-26-054842
- form_type: 8-K
- ticker: BRVE
- cik: 0002131524
- company_name: Braveheart Bio, Inc.
- filed_at: 2026-08-07T20:14:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2131524/000162828026054842/0001628280-26-054842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2131524/000162828026054842/braveheart-closing8xk.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-054842
- JSON: https://secwatch.observer/filing/0001628280-26-054842.json
- Plain text: https://secwatch.observer/filing/0001628280-26-054842.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.